7.1 – 00113 Safety and PD-1 receptor occupancy with low dose Nivolumab in adults living with HIV on antiretroviral therapy: NIVO-LD

• DOI: 10.1016/j.jve.2024.100430
• Publication Date: 2024-12-10T12:57:19Z
• Authors: J.H. McMahon; J.S.Y. Lau; L. Wallace; M. Kaiser; J. Chang; A. Solomon; B. Scher; P. Beech; D. Price; T.A. Rasmussen; S.R. Lewin